Roberta Razzetti

581 total citations
38 papers, 464 citations indexed

About

Roberta Razzetti is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Physiology. According to data from OpenAlex, Roberta Razzetti has authored 38 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Cardiology and Cardiovascular Medicine and 11 papers in Physiology. Recurrent topics in Roberta Razzetti's work include Neonatal Respiratory Health Research (6 papers), Neuroscience of respiration and sleep (6 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Roberta Razzetti is often cited by papers focused on Neonatal Respiratory Health Research (6 papers), Neuroscience of respiration and sleep (6 papers) and Cardiac electrophysiology and arrhythmias (6 papers). Roberta Razzetti collaborates with scholars based in Italy, France and Bulgaria. Roberta Razzetti's co-authors include S Bongrani, P Schiantarelli, Maurizio Civelli, Daniela Acerbi, Giuseppe Rossoni, Federico Bianco, Ferruccio Berti, Barbara Manfredi, Francesca Ricci and M. A. C. M. Bergamaschi and has published in prestigious journals such as PLoS ONE, The American Journal of Cardiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Roberta Razzetti

38 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Razzetti Italy 13 194 135 95 90 88 38 464
Antonio Esteras Spain 10 98 0.5× 47 0.3× 150 1.6× 242 2.7× 20 0.2× 16 619
Janine Bessard France 13 126 0.6× 85 0.6× 111 1.2× 135 1.5× 10 0.1× 18 637
William Simpson United Kingdom 9 140 0.7× 93 0.7× 157 1.7× 79 0.9× 11 0.1× 19 460
Goutam Ghosh India 8 39 0.2× 67 0.5× 62 0.7× 110 1.2× 64 0.7× 23 441
Kunio Sato Japan 10 87 0.4× 73 0.5× 151 1.6× 193 2.1× 12 0.1× 31 551
E. Karge Germany 12 26 0.1× 128 0.9× 181 1.9× 81 0.9× 39 0.4× 43 491
Robert L. Wendt United States 14 66 0.3× 310 2.3× 87 0.9× 194 2.2× 16 0.2× 33 615
M.T. Tacconi Italy 15 61 0.3× 42 0.3× 96 1.0× 158 1.8× 19 0.2× 35 537
Ulrich Riederer Germany 7 41 0.2× 205 1.5× 241 2.5× 93 1.0× 55 0.6× 9 498
R. Ceserani Italy 14 63 0.3× 31 0.2× 132 1.4× 102 1.1× 16 0.2× 52 530

Countries citing papers authored by Roberta Razzetti

Since Specialization
Citations

This map shows the geographic impact of Roberta Razzetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Razzetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Razzetti more than expected).

Fields of papers citing papers by Roberta Razzetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Razzetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Razzetti. The network helps show where Roberta Razzetti may publish in the future.

Co-authorship network of co-authors of Roberta Razzetti

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Razzetti. A scholar is included among the top collaborators of Roberta Razzetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Razzetti. Roberta Razzetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ricci, Francesca, et al.. (2016). In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633. Pediatric Research. 81(2). 369–375. 39 indexed citations
2.
Exerowa, D., et al.. (2014). Evaluation of therapeutic pulmonary surfactants by thin liquid film methods. Advances in Colloid and Interface Science. 222. 709–715. 13 indexed citations
3.
Seehase, Matthias, Jennifer J.P. Collins, Elke Kuypers, et al.. (2012). New Surfactant with SP-B and C Analogs Gives Survival Benefit after Inactivation in Preterm Lambs. PLoS ONE. 7(10). e47631–e47631. 73 indexed citations
4.
Rossoni, Giuseppe, Barbara Manfredi, Maurizio Civelli, Ferruccio Berti, & Roberta Razzetti. (2008). Combined simvastatin–manidipine protect against ischemia–reperfusion injury in isolated hearts from normocholesterolemic rats. European Journal of Pharmacology. 587(1-3). 224–230. 12 indexed citations
5.
Fiordaliso, Fabio, Noeleen De Angelis, Antonio Bai, et al.. (2007). Effect of β-adrenergic and renin–angiotensin system blockade on myocyte apoptosis and oxidative stress in diabetic hypertensive rats. Life Sciences. 81(12). 951–959. 22 indexed citations
6.
Razzetti, Roberta, M. A. C. M. Bergamaschi, Gino Villetti, et al.. (2007). Formoterol and beclomethasone dipropionate interact positively in antagonising bronchoconstriction and inflammation in the lung. Pharmacological Research. 55(5). 426–432. 6 indexed citations
7.
Zaniboni, Massimiliano, Monia Savi, Leonardo Bocchi, et al.. (2006). Effects of the ??2-Adrenergic/DA2-Dopaminergic Agonist CHF-1024 in Preventing Ventricular Arrhythmogenesis and Myocyte Electrical Remodeling, in a Rat Model of Pressure-Overload Cardiac Hypertrophy. Journal of Cardiovascular Pharmacology. 47(2). 295–302. 4 indexed citations
8.
Rossoni, Giuseppe, Barbara Manfredi, Roberta Razzetti, et al.. (2005). Positive interaction of the β2‐agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea‐pigs. British Journal of Pharmacology. 144(3). 422–429. 12 indexed citations
9.
Pasini, Evasio, et al.. (2003). Effect of nolomirole on monocrotaline-induced heart failure. Pharmacological Research. 49(1). 1–5. 9 indexed citations
10.
Rossoni, Giuseppe, Barbara Manfredi, Viviana Cavalca, et al.. (2003). The Aminotetraline Derivative (±)-(R,S)-5,6-Dihydroxy-2-methylamino-1,2,3,4-tetrahydro-naphthalene Hydrochloride (CHF-1024) Displays Cardioprotection in Postischemic Ventricular Dysfunction of the Rat Heart. Journal of Pharmacology and Experimental Therapeutics. 307(2). 633–639. 7 indexed citations
11.
Masson, Serge, Stefano Chimenti, Monica Salio, et al.. (2001). CHF-1024, A DA2/α2 Agonist, Blunts Norepinephrine Excretion and Cardiac Fibrosis in Pressure Overload. Cardiovascular Drugs and Therapy. 15(2). 131–138. 16 indexed citations
12.
Bergamaschi, M. A. C. M., et al.. (2000). Receptor Profile of a Potent and Selective DA2/α2 Agonist. European Journal of Heart Failure. 2(S1). 95–95. 4 indexed citations
13.
Razzetti, Roberta, et al.. (2000). Haemodynamic and Neurohormones Release Inhibiting Effects of a DA2/α2 Agonist. European Journal of Heart Failure. 2(S1). 94–94. 5 indexed citations
14.
15.
Latini, Roberto, Serge Masson, Fabio Fiordaliso, et al.. (1998). Comparative Efficacy of a DA2/α2 Agonist and a β-Blocker in Reducing Adrenergic Drive and Cardiac Fibrosis in an Experimental Model of Left Ventricular Dysfunction After Coronary Artery Occlusion. Journal of Cardiovascular Pharmacology. 31(4). 601–608. 25 indexed citations
16.
17.
Civelli, Maurizio, Paola Caruso, Roberta Razzetti, et al.. (1996). The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363. British Journal of Pharmacology. 118(4). 923–928. 27 indexed citations
18.
Razzetti, Roberta & Daniela Acerbi. (1995). Pharmacokinetic and pharmacologic properties of delapril, a lipophilic nonsulfhydryl angiotensin-converting enzyme inhibitor. The American Journal of Cardiology. 75(16). 7F–12F. 25 indexed citations
19.
20.
Razzetti, Roberta, S Bongrani, & P Schiantarelli. (1984). In vitro effects of nicarpidine on vascular and cardiac muscle preparations. Pharmacological Research Communications. 16(8). 795–808. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonio Esteras Breakdown of academic impact, for papers by Janine Bessard Breakdown of academic impact, for papers by William Simpson Breakdown of academic impact, for papers by Goutam Ghosh Breakdown of academic impact, for papers by Kunio Sato Breakdown of academic impact, for papers by E. Karge Breakdown of academic impact, for papers by Robert L. Wendt Breakdown of academic impact, for papers by M.T. Tacconi Breakdown of academic impact, for papers by Ulrich Riederer Breakdown of academic impact, for papers by R. Ceserani
Rankless by CCL
2026